Where can I buy Avnibu tablets?

Ivonib is already on the domestic market, but it is currently not included in the medical insurance system, which means that patients need to bear all costs when purchasing it. Nonetheless, it is certainly a worthwhile investment for patients who are in dire need of this medication. They can choose to go directly to the hospital pharmacy for consultation and purchase, or obtain the medicine through formal and legal overseas channels.

Avosidenib's primary therapeutic target is adults with relapsed or refractory acute myeloid leukemia (AML) diagnosed by a well-validated test as carrying an IDH1 mutation. The drug is unique in that it precisely inhibits the mutated IDH1 enzyme, thereby reducing the production of a metabolite called 2-HG in tumor cells. It is this mechanism that makes ivonib play a vital role in anti-tumor treatment.

Regarding the medication guidance of ivonib, the recommended dose is 500mg per day, taken orally, and only needs to be taken once a day. Patients can choose to take it before or after meals, but in order to avoid affecting the efficacy of the drug, they should avoid taking it at the same time with high-fat foods. In addition, please note that the tablets should be swallowed whole and should not be broken, crushed or chewed. To ensure the stability of blood drug concentrations, it is recommended that patients take the drug at the same time every day.

Avosidenib’s performance in clinical trials has been impressive. Research results on AML patients carrying IDH1 mutations show that ivonib can effectively inhibit the activity of abnormal IDH1 mutant genes, thereby significantly reducing the proliferation rate of leukemia cells. What is even more exciting is that clinical trial data also show that patients using ivonib have significantly improved survival and quality of life.

Of course, any drug may cause certain adverse reactions. But thankfully, most of the adverse reactions caused by ivonib are controllable. Common adverse reactions mainly include nausea, diarrhea and fatigue, but these symptoms are usually mild to moderate and will not have a serious impact on the patient's daily life. Moreover, with appropriate supportive care, these adverse reactions can be effectively managed.